A detailed history of Raleigh Capital Management Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 4,192 shares of MDT stock, worth $334,856. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,192
Previous 4,866 13.85%
Holding current value
$334,856
Previous $383,000 1.57%
% of portfolio
0.15%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$76.84 - $91.03 $51,790 - $61,354
-674 Reduced 13.85%
4,192 $377,000
Q2 2024

Jul 31, 2024

BUY
$78.71 - $87.02 $21,409 - $23,669
272 Added 5.92%
4,866 $383,000
Q1 2024

May 13, 2024

SELL
$82.84 - $88.09 $1.15 Million - $1.22 Million
-13,864 Reduced 75.11%
4,594 $400,000
Q4 2023

Feb 21, 2024

SELL
$69.43 - $83.43 $47,073 - $56,565
-678 Reduced 3.54%
18,458 $1.52 Million
Q3 2023

Dec 07, 2023

BUY
$78.22 - $90.4 $13,375 - $15,458
171 Added 0.9%
19,136 $1.5 Million
Q3 2023

Dec 06, 2023

BUY
$78.22 - $90.4 $155,657 - $179,896
1,990 Added 11.72%
18,965 $1.49 Million
Q2 2023

Jul 25, 2023

SELL
$79.47 - $91.38 $108,873 - $125,190
-1,370 Reduced 7.47%
16,975 $1.5 Million
Q1 2023

May 22, 2023

BUY
$76.72 - $87.58 $58,153 - $66,385
758 Added 4.31%
18,345 $1.48 Million
Q4 2022

Feb 07, 2023

BUY
$76.18 - $87.74 $963,219 - $1.11 Million
12,644 Added 255.8%
17,587 $1.37 Million
Q3 2022

Nov 09, 2022

BUY
$80.75 - $95.31 $28,827 - $34,025
357 Added 7.78%
4,943 $399,000
Q2 2022

Aug 30, 2022

BUY
$87.4 - $113.09 $21,150 - $27,367
242 Added 5.57%
4,586 $412,000
Q1 2022

May 12, 2022

BUY
$100.58 - $112.38 $110,939 - $123,955
1,103 Added 34.03%
4,344 $482,000
Q4 2021

Feb 16, 2022

BUY
$99.53 - $127.75 $322,576 - $414,037
3,241 New
3,241 $335,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $106B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.